{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:01:50Z","timestamp":1790798510684,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejmech.2019.111791","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:30:05Z","timestamp":1571311805000},"page":"111791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Current scenario of ferrocene-containing hybrids for antimalarial activity"],"prefix":"10.1016","volume":"185","author":[{"given":"Jiaqi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111791_bib1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1039\/c1nj20172g","article-title":"Application of ferrocene and its derivatives in cancer research","volume":"35","author":"Ornelas","year":"2011","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib2","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/om400446y","article-title":"A\u00a0new age for iron: antitumoral ferrocenes","volume":"32","author":"Braga","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2019.111791_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ccr.2019.06.004","article-title":"Ferrocene derivatives as anti-infective agents","volume":"396","author":"Ludwig","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111791_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molstruc.2017.12.089","article-title":"Synthesis of novel ferrocenyl Mannich bases and their antibacterial activities","volume":"1157","author":"Liu","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2019.111791_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jorganchem.2017.11.015","article-title":"Design, synthesis and fungicidal activity studies of 3-ferrocenyl-N-acryloylmorpholine","volume":"854","author":"Chen","year":"2018","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib6","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jorganchem.2010.09.015","article-title":"Evaluation of bactericidal and fungicidal activity of ferrocenyl or phenyl derivatives in the diphenyl butene series","volume":"696","author":"El-Arbi","year":"2011","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4155\/fmc.12.26","article-title":"Ferrocene-based antimalarials","volume":"4","author":"Roux","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/aoc.1202","article-title":"On the medicinal chemistry of ferrocene","volume":"21","author":"Fouda","year":"2007","journal-title":"Applied Organonet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111791_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrids molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib11","article-title":"Hybrid molecules with potential in\u00a0vitro antiplasmodial and in\u00a0vivo antimalarial activity against drug-resistant Plasmodium falciparum","author":"Feng","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.111791_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16154-2","article-title":"The next generation antimalarial drug, has antitumor activity","volume":"7","author":"Kondratskyi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111791_bib13","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/molecules13112900","article-title":"Ferroquine, an ingenious antimalarial drug -thoughts on the mechanism of action","volume":"13","author":"Dubar","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111791_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2015.07.009","article-title":"Ferroquine and its derivatives: new generation of antimalarial agents","volume":"101","author":"Wani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib15","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1186\/1475-2875-10-53","article-title":"Phase I randomized dose-ascending placebo-controlled trials of ferroquine-a candidate anti-malarial drug-in adults with asymptomatic Plasmodium falciparum infection","volume":"10","author":"Mombo-Ngoma","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2019.111791_bib16","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1186\/s12936-016-1511-3","article-title":"A\u00a0Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood stage malaria infection study","volume":"15","author":"McCarthy","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2019.111791_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(15)00079-1","article-title":"Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study","volume":"15","author":"Held","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111791_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1473-3099(15)00148-6","article-title":"Welcome to the next generation of antimalarials","volume":"15","author":"Wells","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.111791_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.111791_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib21","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A gift from traditional Chinese medicine to the world (Nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111791_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-018-0259-3","article-title":"Monitoring the efficacy and safety of artemisinin-based combination therapies: a review and network meta-analysis of antimalarial therapeutic efficacy trials in Cameroon","volume":"19","author":"Whegang","year":"2019","journal-title":"Drugs R"},{"key":"10.1016\/j.ejmech.2019.111791_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMp1901233","article-title":"A\u00a0temporizing solution to artemisinin resistance","volume":"380","author":"Wang","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.111791_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.111791_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00044-016-1778-5","article-title":"The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review","volume":"26","author":"Dai","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111791_bib26","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anti-cancer agents","volume":"59","author":"Frohlich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib27","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1021\/jm400004u","article-title":"Comparative antimalarial activities and ADME profiles of Ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres","volume":"56","author":"Wang","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib29","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0968-0896(00)00206-6","article-title":"Novel ferrocenic artemisinin derivatives: synthesis, in\u00a0vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX","volume":"8","author":"Delhaes","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bmc.2018.11.018","article-title":"Synthesis of new betulinic acid\/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities","volume":"27","author":"Karag\u04e7z","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bmcl.2017.12.057","article-title":"Vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives","volume":"28","author":"Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111791_bib33","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2018.08.037","article-title":"Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids","volume":"28","author":"Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111791_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib35","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib36","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"Vandekerckhoe","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib37","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/S0968-0896(99)00224-2","article-title":"Synthesis and antimalarial activity in\u00a0vitro of potential metabolites of ferrochloroquine and related compounds","volume":"7","author":"Biot","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib38","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/jm9018383","article-title":"Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA","volume":"53","author":"Wenzel","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib39","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1021\/jm060259d","article-title":"Probing the role of the covalent linkage of ferrocene into a chloroquine template","volume":"49","author":"Biot","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib40","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in\u00a0vitro and in\u00a0vivo of a new ferrocene-chloroquine analog","volume":"40","author":"Biot","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib41","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/jm301422h","article-title":"Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms","volume":"56","author":"Salas","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejmech.2014.01.023","article-title":"Design, synthesis and biological evaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents","volume":"75","author":"Inam","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2014.11.065","article-title":"Synthesis and in\u00a0vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives","volume":"90","author":"Maguene","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jorganchem.2003.07.026","article-title":"Synthesis and antimalarial activity in\u00a0vitro of new heterobimetallic complexes: Rh and Au derivatives of chloroquine and a series of ferrocenyl-4-amino-7-chloroquinolines","volume":"688","author":"Blackie","year":"2003","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00044-013-0748-4","article-title":"In\u00a0vitro antiplasmodial and antiproliferative activities of a series of quinoline-ferrocene hybrids","volume":"23","author":"N\u2019Da","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111791_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bcp.2005.10.023","article-title":"Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum","volume":"71","author":"Molyneaux","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111791_bib47","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/AAC.05345-11","article-title":"Novel potent metallocenes against liver stage malaria","volume":"56","author":"Matos","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111791_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0223-5234(00)00178-1","article-title":"Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents","volume":"35","author":"Biot","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib49","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1016\/j.bmc.2007.07.012","article-title":"Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in\u00a0vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum","volume":"15","author":"Blackie","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejmech.2019.06.023","article-title":"Ferroquine-derived polyamines that target resistant Plasmodium falciparum","volume":"179","author":"Stringer","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib51","first-page":"627","article-title":"Cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines","volume":"60","author":"N\u2019Da","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2019.111791_bib52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-0031-1296211","article-title":"Synthesis and in\u00a0vitro antiplasmodial activity of quinoline-ferrocene esters","volume":"61","author":"N\u2019Da","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2019.111791_bib53","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1039\/C6DT03175G","article-title":"Bioisosteric ferrocenyl-containing quinolines with antiplasmodial and antitrichomonal properties","volume":"45","author":"Adams","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2019.111791_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jorganchem.2012.06.025","article-title":"Synthesis of 2-ferrocenylquinoline derivatives and evaluation of their antimalarial activity","volume":"716","author":"Patti","year":"2012","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib55","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.jorganchem.2004.04.036","article-title":"Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates","volume":"689","author":"Biot","year":"2004","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib56","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1039\/C7MT00196G","article-title":"Platinum(II)-chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function","volume":"9","author":"Macedo","year":"2017","journal-title":"Metall"},{"key":"10.1016\/j.ejmech.2019.111791_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2015.03.045","article-title":"Synthesis and in\u00a0vitro antiplasmodial evaluation of 7-chloroquinolineechalcone and 7-chloroquinoline-ferrocenylchalcone conjugates","volume":"95","author":"Raj","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmech.2019.06.069","article-title":"Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: antimicrobial evaluation and mechanistic insights","volume":"180","author":"Baartzes","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib59","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1016\/j.bmcl.2007.10.003","article-title":"Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues","volume":"17","author":"Biot","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111791_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","article-title":"4-Aminoquinoline-ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib61","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cbdd.12982","article-title":"Piperazine linked 4-aminoquinoline-chalcone\/ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation","volume":"90","author":"Singh","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111791_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2013.05.023","article-title":"Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents","volume":"66","author":"Pandey","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib63","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1039\/c2dt12050j","article-title":"1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents","volume":"41","author":"Herrmann","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2019.111791_bib64","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/om300354x","article-title":"1,1\u2032-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials","volume":"31","author":"Herrmann","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2019.111791_bib65","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1021\/om300392q","article-title":"Modular synthesis of 1,2- and 1,1\u2032-disubstituted ferrocenyl carbohydrate chloroquine and mefloquine conjugates as potential antimalarial agents","volume":"31","author":"Herrmann","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2019.111791_bib66","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1016\/j.bmc.2009.10.008","article-title":"Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker","volume":"17","author":"Chavain","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.04.043","article-title":"Antibacterial activity study of 1,2,4-triazole derivatives","volume":"173","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib70","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib71","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.inoche.2013.06.019","article-title":"Organometallic benzimidazoles: synthesis, characterization and antimalarial activity","volume":"35","author":"Toro","year":"2013","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111791_bib72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0040-4039(00)02106-7","article-title":"Novel N-ferrocenylmethyl, N\u2019-methyl-2-substituted benzimidazolium iodide salts with in\u00a0vitro activity against the P.\u00a0falciparum malarial parasite strain NF54","volume":"42","author":"Howarth","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111791_bib73","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/j.bmc.2016.09.013","article-title":"Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents","volume":"24","author":"Filho","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib74","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"A\u00a0privilege structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111791_bib75","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2018.03.047","article-title":"A\u00a0comprehensive review of chalcone derivatives as antileishmanial agents","volume":"150","author":"de Mello","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib76","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0960-894X(02)00430-4","article-title":"Antimalarial activity of ferrocenyl chalcones","volume":"12","author":"Wu","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111791_bib77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00044-016-1509-y","article-title":"Synthesis and in\u00a0vitro biological activities of ferrocenyl-chalcone amides","volume":"25","author":"Smit","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111791_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jorganchem.2012.08.024","article-title":"Cyrhetrenyl chalcones: synthesis, characterization and antimalarial evaluation","volume":"723","author":"Arancibia","year":"2013","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molstruc.2014.12.070","article-title":"Ferrocenyl-cymantrenyl hetero-bimetallic chalcones: synthesis, structure and biological properties","volume":"1085","author":"Mishra","year":"2015","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2019.111791_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: an overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib82","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1021\/jm901357n","article-title":"Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug\/bioorganometallic approach","volume":"52","author":"Dubar","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib83","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1016\/j.bmc.2008.09.038","article-title":"New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in\u00a0vitro antimalarial activity","volume":"16","author":"Guillon","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib84","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejmech.2011.03.014","article-title":"New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in\u00a0vitro antimalarial activity-Part II","volume":"46","author":"Guillon","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib85","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0960-894X(00)00313-9","article-title":"Synthesis of novel ferrocenyl sugars and their antimalarial activities","volume":"10","author":"Itoh","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111791_bib86","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1021\/ic061166p","article-title":"Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates","volume":"45","author":"Ferreira","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib87","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bmc.2005.09.054","article-title":"Synthesis and in\u00a0vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum","volume":"14","author":"Baramee","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib88","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejmech.2013.10.011","article-title":"Synthesis and biological evaluation of novel ferrocene-naphthoquinones as antiplasmodial agents","volume":"70","author":"Garcia-Barrantes","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib89","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jinorgbio.2017.04.014","article-title":"Ferrocenyl and organic novobiocin derivatives: synthesis and their in\u00a0vitro biological activity","volume":"172","author":"Mbaba","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2019.111791_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2014.08.053","article-title":"1H-1,2,3-triazole tethered mono- and bis-ferrocenylchalcone-\u03b2-lactam conjugates: synthesis and antimalarial evaluation","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib91","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jorganchem.2010.11.021","article-title":"Ferrocene-indole hybrids for cancer and malaria therapy","volume":"696","author":"Quirante","year":"2011","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib92","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejmech.2014.10.024","article-title":"1H-1,2,3-triazole tethered isatin-ferrocene conjugates: synthesis and in\u00a0vitro antimalarial evaluation","volume":"87","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.05.043","article-title":"Ferrocene-pyrimidine conjugates: synthesis, electrochemistry, physicochemical properties and antiplasmodial activities","volume":"100","author":"Chopra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2014.01.051","article-title":"Synthesis of 4\u2019-(2-ferrocenyl)-2,2\u2019:6\u20192\u2019\u2019-terpyridine: characterization and antiprotozoal activity of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) complexes","volume":"75","author":"Juneja","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib95","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1039\/C8DT04263B","article-title":"Evaluation of ferrocenyl phosphines as potent antimalarials targeting the digestive vacuole function of Plasmodium falciparum","volume":"48","author":"Subramanian","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2019.111791_bib96","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jorganchem.2012.08.034","article-title":"Platinum(II) and gold(I) complexes based on 1,10-bis(diphenylphosphino)metallocene derivatives: synthesis, characterization and biological activity of the gold complexes","volume":"720","author":"Bjelosevic","year":"2012","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2019.111791_bib97","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1039\/c1nj20551j","article-title":"One-pot microwave-assisted synthesis and antimalarial activity of ferrocenyl benzodiazepines","volume":"35","author":"Mwande-Maguene","year":"2011","journal-title":"New J. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419309432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:58:16Z","timestamp":1759327096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419309432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":97,"alternative-id":["S0223523419309432"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111791","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current scenario of ferrocene-containing hybrids for antimalarial activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111791"}}